Maximum quantity allowed is 999
Please select the quantity
CAS RN: 136470-78-5 | Product Number: A2694
Abacavir
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 1G |
₩185,000
|
33 | 7 | Contact Us | |
| 5G |
₩590,200
|
7 | 9 | Contact Us |
* Please contact our distributor of SEJIN CI Co., Ltd.
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination. SEJIN CI Co., Ltd. (Phone: 02-2655-2480 / email:
sales@sejinci.co.kr)
* The storage conditions are subject to change without notice.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
| Product Number | A2694 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__4H__1__8N__6O = 286.34 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 136470-78-5 |
| Reaxys Registry Number | 7493116 |
| PubChem Substance ID | 253661597 |
| Merck Index (14) | 1 |
| MDL Number | MFCD00903850 |
Specifications
| Appearance | White to Light yellow to Light orange powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Specific rotation [a]20/D | -53.0 to -57.0 deg(C=0.15, MeOH) |
Properties (reference)
| Melting Point | 161 °C(dec.) |
| Specific Rotation | -54° (C=0.15,MeOH) |
| Solubility in water | Insoluble |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. H317 : May cause an allergic skin reaction. H334 : May cause allergy or asthma symptoms or breathing difficulties if inhaled. H341 : Suspected of causing genetic defects. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P272 : Contaminated work clothing should not be allowed out of the workplace. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P284 : Wear respiratory protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P362 + P364 : Take off contaminated clothing and wash it before reuse. P304 + P340 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. P405 : Store locked up. |
Related Laws:
| RTECS# | GY5979200 |
Transport Information:
| H.S.code* | 2933.59-000 |
Application
Abacavir: A Nucleoside Analog Reverse Transcriptase Inhibitor (RTI)
Abacavir is a nucleoside analog reverse transcriptase inhibitor (RTI) that inhibits HIV-1 in vitro with a potency similar to that of zidovudine [A2052]. Resistance to abacavir develops relatively slowly. Cross-resistance between abacavir and other RTIs, namely didanosine [D3066], zalcitabine [D3581] or lamivudine [L0217], but not zidovudine or stavudine [D3580], has been reported in vitro. HLA-B*5701 genetic screening have been reported to prevent drug hypersensitivity reactions caused by abacavir.
References
- Abacavir (a review)
- The antiviral activity, mechanism of action, clinical significance and resistance of abacavir in the treatment of pediatric AIDS (a review)
- HLA-B*5701 screening prior to abacavir prescription: Clinical and laboratory aspects (a review)
- Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.